Back
Zymeworks 10K Form
Buy
62
ZYME
Zymeworks
Last Price:
14.29
Seasonality Move:
9.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-05 | 10Q | ZYME/Zymeworks Quarterly |
2020-05-07 | 10Q | ZYME/Zymeworks Quarterly |
2020-03-02 | 10K | ZYME/Zymeworks Annual |
2019-11-05 | 10Q | ZYME/Zymeworks Quarterly |
2019-08-02 | 10Q | ZYME/Zymeworks Quarterly |
2019-05-02 | 10Q | ZYME/Zymeworks Quarterly |
Receive ZYME News And Ratings
See the #1 stock for the next 7 days that we like better than ZYME
ZYME Financial Statistics
Sales & Book Value
Annual Sales: | $76.01M |
---|---|
Cash Flow: | $-6.88M |
Price / Cash Flow: | 0 |
Annual Sales: | $5.27 |
Price / Book: | 2.68 |
Profitability
EPS (TTM): | -1.49000 |
---|---|
Net Income (TTM): | $-113.67M |
Gross Margin: | $11.09M |
Return on Equity: | -27.06% |
Return on Assets: | -21.1% |
Zymeworks Earnings Forecast
Key Zymeworks Financial Ratios
- The Gross Profit Margin over the past 4 years for ZYME is 21.43%.
- The Selling, General & Administrative Expenses for ZYME have been equal to 92.62% of Gross Profit Margin.
- The Research & Development expenses have been 188.94% of Revenue.
- The Interest Expense is -0.46% of Operating Income.
- The Net Earning history of ZYME is -156.13% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 3 years.
Zymeworks Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | ZYME |
CUSIP: | 98985W |
Website: | zymeworks.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.1 |
Quick Ratio: | 3.82 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |